Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...

More than seven million Americans have Alzheimer’s disease, and two-thirds of them are women, according to the Alzheimer’s ...

The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...

CDK2-mediated TBK1 degradation via Dtx4 represents a previously unrecognized regulatory mechanism that modulates antiviral immunity in fish.

The interferon regulatory factor (IRF) family of transcription factors, pivotal for initiating antiviral type I interferon ...

Itaconate, an endogenous mitochondrial metabolite produced by the enzyme aconitate decarboxylase 1 (ACOD1), has emerged as a central regulator of ...

Systemic Lupus Erythematosus is one of the most complex autoimmune diseases seen in modern medicine, affecting multiple organs and presenting differently from one patient to another. Often referred to ...

When war breaks out, power plants are attacked first along with military facilities like air defense networks. The same thing happens in the war inside the human body. Cancer cells have been found to ...

OS Therapies releases trial data supporting FDA approval, U.K. and U.S. timelines, and potential eligibility for a valuable ...

Published on January 6, 2026, in Volume 2 of the Immunity & Inflammation journal, the review begins by underscoring Professor Taniguchi's ...

Hijacking the energy-producing organelles from immune cells seems to help tumours in mice to infiltrate lymph nodes.

Among the most famous demonstrations of genetic mutations driving infection outcome is severe combined immunodeficiency (SCID ...